Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease

International Journal of Alzheimer's Disease - United States
doi 10.1155/2012/628070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Targeting Soluble Amyloid Oligomers in Alzheimer's Disease Through Disordered Prion Peptides

Biophysical Journal
Biophysics
2019English

Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A

Journal of Neuroscience
Neuroscience
2012English

Simulation of Ca2+ Oscillations in Astrocytes Mediated by Amyloid Beta in Alzheimer's Disease

2020English

Amyloid Beta Proteins Modified by PUFA Oxidation Products in Alzheimer's Disease Brain

Biophysical Journal
Biophysics
2018English

Blood-Borne Amyloid- Dimer Correlates With Clinical Markers of Alzheimer's Disease

Journal of Neuroscience
Neuroscience
2010English

Apolipoprotein J and Alzheimer's Amyloid .BETA. Solubility.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1999English

Understanding Amyloid and Alzheimer's Disease

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2012English

Extracting -Amyloid From Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

A Bifunctional Curcumin Analogue for Two-Photon Imaging and Inhibiting Crosslinking of Amyloid Beta in Alzheimer's Disease

Chemical Communications
SurfacesAlloysMaterials ChemistryCoatingsMetalsOpticalMagnetic MaterialsFilmsCatalysisChemistryElectronicCompositesCeramics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy